Hepata-Chord
- Manufacturer
- Energetix Corp
- Effective date
- 2021-12-20
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 6
- Source
- full-release
- Hydrated at
- 2026-06-01 02:15:14
Label at a glance#
ProductHepata-Chord
Active ingredientACETIC ACID, ASPIRIN, ALUMINUM OXIDE, BENZENE, BERBERIS VULGARIS ROOT BARK, MILK THISTLE, CHELIDONIUM MAJUS, CHELONE GLABRA, CHLORAMPHENICOL, CHLORPROMAZINE, CHOLESTEROL, CORTISONE ACETATE, ESTRONE, GAMBOGE, PORK LIVER, CENTELLA ASIATICA, BOS TAURUS HYPOTHALAMUS, ARCTIUM LAPPA ROOT, SODIUM SULFATE, PARAFFIN, KEROSENE, PHENACETIN, PHOSPHORUS, SILICON DIOXIDE, TARAXACUM OFFICINALE, THYROID, UNSPECIFIED
Label structure8 sections
Contacts and useful links#
Websitewww.goenergetix.com
www.goenergetix.com
www.goenergetix.comLabel contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredients 59.1 mL contains 3.22% of: Aceticum ac 18X; Acetylsalicylicum ac 18X; Alumina 18X; Benzinum 12X; Berberis vulg 4X; Carduus mar 4X; Chelidonium maj 4X; Chelone 12X; Chloramphenicolum 18X; Chlorpromazinum 18X; Cholesterinum 12X; Cortisone aceticum 18X; Folliculinum 18X; Gambogia 12X; Hepar suis 9X, 12X, 6C; Hydrocotyle 5X; Hypothalamus 12X, 6C; Lappa 4X; Nat sulphuricum 12X, 30X; Petroleum 18X; Phenacetinum 18X; Phos 12X; Silicea 12X; Taraxacum 4X; Thyroidinum 9X, 12X, 6C.
Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
INDICATIONS & USAGE SECTION
Uses
Temporary relief of skin rash, right-side abdominal discomfort, headache
WARNINGS SECTION
Warnings
- In case of overdose, get medical help or contact a Poison Control Center right away.
- If pregnant or breast feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
• Keep out of reach of children.
DOSAGE & ADMINISTRATION SECTION
Directions
- Take 30 drops orally twice daily or as directed by a healthcare professional.
- Consult a physician for use in children under 12 years of age or if symptoms worsen or persist.
OTHER SAFETY INFORMATION
Other information
- Store at room temperature out of direct sunlight.
- Do not use if neck wrap is broken or missing.
- Shake well before use.
INACTIVE INGREDIENT SECTION
Inactive ingredients
Ethyl Alcohol, Glycerin, Purified Water.
OTC - QUESTIONS SECTION
Distributed by Energetix Corp.
Dahlonega, GA 30533
Questions? Comments?
800.990.7085
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
energetix®
Hepata-Chord
Homeopathic Remedy
Skin rash, right-side abdominal discomfort, headache
2 fl oz (59.1 mL) / 15% Ethyl Alcohol
OTC - PURPOSE SECTION
Purpose Temporary relief of skin rash, right-side abdominal discomfort, headache.
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 64578-0064-1 | Hepata-Chord | 59.1 mL in 1 BOTTLE, DROPPER | LIQUID | 59.1 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 64578-0064 | HEPATA-CHORD (HOMEOPATHIC LIQUID) LIQUID [ENERGETIX CORP] | 6 | Legacy NDC, 1 package rows | 20211221_64655edd-9f91-4278-af1e-01a8461daf0f.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ACETIC ACID | ACTIVE INGREDIENT | Q40Q9N063P | 1 | |
| ALUMINUM OXIDE | ACTIVE INGREDIENT | LMI26O6933 | 1 | |
| ARCTIUM LAPPA ROOT | ACTIVE INGREDIENT | 597E9BI3Z3 | 1 | |
| ASPIRIN | ACTIVE INGREDIENT | R16CO5Y76E | 1 | |
| BENZENE | ACTIVE INGREDIENT | J64922108F | 1 | |
| BERBERIS VULGARIS ROOT BARK | ACTIVE INGREDIENT | 1TH8Q20J0U | 1 | |
| BOS TAURUS HYPOTHALAMUS | ACTIVE INGREDIENT | S6G2NLH4Y7 | 1 | |
| CENTELLA ASIATICA | ACTIVE INGREDIENT | 7M867G6T1U | 1 | |
| CHELIDONIUM MAJUS | ACTIVE INGREDIENT | 7E889U5RNN | 1 | |
| CHELONE GLABRA | ACTIVE INGREDIENT | 6G3UN932VF | 1 | |
| CHLORAMPHENICOL | ACTIVE INGREDIENT | 66974FR9Q1 | 1 | |
| CHLORPROMAZINE | ACTIVE INGREDIENT | U42B7VYA4P | 1 | |
| CHOLESTEROL | ACTIVE INGREDIENT | 97C5T2UQ7J | 1 | |
| CORTISONE ACETATE | ACTIVE INGREDIENT | 883WKN7W8X | 1 | |
| ESTRONE | ACTIVE INGREDIENT | 2DI9HA706A | 1 | |
| GAMBOGE | ACTIVE INGREDIENT | 7556HJ7587 | 1 | |
| KEROSENE | ACTIVE INGREDIENT | 1C89KKC04E | 1 | |
| MILK THISTLE | ACTIVE INGREDIENT | U946SH95EE | 1 | |
| PARAFFIN | ACTIVE INGREDIENT | I9O0E3H2ZE | 1 | |
| PHENACETIN | ACTIVE INGREDIENT | ER0CTH01H9 | 1 | |
| PHOSPHORUS | ACTIVE INGREDIENT | 27YLU75U4W | 1 | |
| PORK LIVER | ACTIVE INGREDIENT | 6EC706HI7F | 1 | |
| SILICON DIOXIDE | ACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| SODIUM SULFATE | ACTIVE INGREDIENT | 0YPR65R21J | 1 | |
| TARAXACUM OFFICINALE | ACTIVE INGREDIENT | 39981FM375 | 1 | |
| THYROID, UNSPECIFIED | ACTIVE INGREDIENT | 0B4FDL9I6P | 1 | |
| ACETIC ACID | ACTIVE MOIETY | Q40Q9N063P | 1 | |
| ALUMINUM OXIDE | ACTIVE MOIETY | LMI26O6933 | 1 | |
| ARCTIUM LAPPA ROOT | ACTIVE MOIETY | 597E9BI3Z3 | 1 | |
| ASPIRIN | ACTIVE MOIETY | R16CO5Y76E | 1 | |
| BENZENE | ACTIVE MOIETY | J64922108F | 1 | |
| BERBERIS VULGARIS ROOT BARK | ACTIVE MOIETY | 1TH8Q20J0U | 1 | |
| BOS TAURUS HYPOTHALAMUS | ACTIVE MOIETY | S6G2NLH4Y7 | 1 | |
| CENTELLA ASIATICA | ACTIVE MOIETY | 7M867G6T1U | 1 | |
| CHELIDONIUM MAJUS | ACTIVE MOIETY | 7E889U5RNN | 1 | |
| CHELONE GLABRA | ACTIVE MOIETY | 6G3UN932VF | 1 | |
| CHLORAMPHENICOL | ACTIVE MOIETY | 66974FR9Q1 | 1 | |
| CHLORPROMAZINE | ACTIVE MOIETY | U42B7VYA4P | 1 | |
| CHOLESTEROL | ACTIVE MOIETY | 97C5T2UQ7J | 1 | |
| COLLOIDAL SILICON DIOXIDE | ACTIVE MOIETY | ETJ7Z6XBU4 | 1 | |
| CORTISONE | ACTIVE MOIETY | V27W9254FZ | 1 | |
| ESTRONE | ACTIVE MOIETY | 2DI9HA706A | 1 | |
| GAMBOGE | ACTIVE MOIETY | 7556HJ7587 | 1 | |
| KEROSENE | ACTIVE MOIETY | 1C89KKC04E | 1 | |
| MILK THISTLE | ACTIVE MOIETY | U946SH95EE | 1 | |
| PARAFFIN | ACTIVE MOIETY | I9O0E3H2ZE | 1 | |
| PHENACETIN | ACTIVE MOIETY | ER0CTH01H9 | 1 | |
| PHOSPHORUS | ACTIVE MOIETY | 27YLU75U4W | 1 | |
| PORK LIVER | ACTIVE MOIETY | 6EC706HI7F | 1 | |
| SODIUM SULFATE ANHYDROUS | ACTIVE MOIETY | 36KCS0R750 | 1 | |
| TARAXACUM OFFICINALE | ACTIVE MOIETY | 39981FM375 | 1 | |
| THYROID, UNSPECIFIED | ACTIVE MOIETY | 0B4FDL9I6P | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- Hepata-Chord
- Homeopathic Liquid
- ACETIC ACID
- ASPIRIN
- ALUMINUM OXIDE
- BENZENE
- BERBERIS VULGARIS ROOT BARK
- MILK THISTLE
- CHELIDONIUM MAJUS
- CHELONE GLABRA
- CHLORAMPHENICOL
- CHLORPROMAZINE
- CHOLESTEROL
- CORTISONE ACETATE
- CORTISONE
- ESTRONE
- GAMBOGE
- PORK LIVER
- CENTELLA ASIATICA
- BOS TAURUS HYPOTHALAMUS
- ARCTIUM LAPPA ROOT
- SODIUM SULFATE
- SODIUM SULFATE ANHYDROUS
- PARAFFIN
- KEROSENE
- PHENACETIN
- PHOSPHORUS
- SILICON DIOXIDE
- TARAXACUM OFFICINALE
- THYROID, UNSPECIFIED
- WATER
- GLYCERIN
- ALCOHOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 64578-0064 | 64578-0064-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ACETIC ACID | Q40Q9N063P | ACTIB |
| ASPIRIN | R16CO5Y76E | ACTIB |
| ALUMINUM OXIDE | LMI26O6933 | ACTIB |
| BENZENE | J64922108F | ACTIB |
| BERBERIS VULGARIS ROOT BARK | 1TH8Q20J0U | ACTIB |
| MILK THISTLE | U946SH95EE | ACTIB |
| CHELIDONIUM MAJUS | 7E889U5RNN | ACTIB |
| CHELONE GLABRA | 6G3UN932VF | ACTIB |
| CHLORAMPHENICOL | 66974FR9Q1 | ACTIB |
| CHLORPROMAZINE | U42B7VYA4P | ACTIB |
| CHOLESTEROL | 97C5T2UQ7J | ACTIB |
| CORTISONE ACETATE | 883WKN7W8X | ACTIB |
| ESTRONE | 2DI9HA706A | ACTIB |
| GAMBOGE | 7556HJ7587 | ACTIB |
| PORK LIVER | 6EC706HI7F | ACTIB |
| CENTELLA ASIATICA | 7M867G6T1U | ACTIB |
| BOS TAURUS HYPOTHALAMUS | S6G2NLH4Y7 | ACTIB |
| ARCTIUM LAPPA ROOT | 597E9BI3Z3 | ACTIB |
| SODIUM SULFATE | 0YPR65R21J | ACTIB |
| PARAFFIN | I9O0E3H2ZE | ACTIB |
| KEROSENE | 1C89KKC04E | ACTIB |
| PHENACETIN | ER0CTH01H9 | ACTIB |
| PHOSPHORUS | 27YLU75U4W | ACTIB |
| SILICON DIOXIDE | ETJ7Z6XBU4 | ACTIB |
| TARAXACUM OFFICINALE | 39981FM375 | ACTIB |
| THYROID, UNSPECIFIED | 0B4FDL9I6P | ACTIB |
| WATER | 059QF0KO0R | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| ALCOHOL | 3K9958V90M | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d3e9ead9-1324-4fb1-b978-7684fb5ee453 | 64655edd-9f91-4278-af1e-01a8461daf0f | 2021-12-20 | Warnings | d3e9ead9-1324-4fb1-b978-7684fb5ee453 64655edd-9f91-4278-af1e-01a8461daf0f |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.